Epidemiology of drug-induced liver injury in China: A systematic analysis of the Chinese literature including 21 789 patients

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 7, 2013, Pages 825-829

  Zhou, Yuan ^a   Yang, Li ^a   Liao, Zhongli ^a   He, Xiaoyang ^a   Zhou, Yuanyuan ^a   Guo, Hong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antibiotics; China; complementary and alternative medicines; drug induced liver injury; etiology; nonsteroidal anti inflammatory drugs; tuberculostatics

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTILIPEMIC AGENT; ANTITHYROID AGENT; ANTIVIRUS AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CEPHEM DERIVATIVE; CLINDAMYCIN; HERBACEOUS AGENT; HORMONE; IBUPROFEN; IMMUNOMODULATING AGENT; INDOMETACIN; ISONIAZID; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; PHENYLBUTAZONE; PSYCHOTROPIC AGENT; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; SEX HORMONE; SULFONAMIDE; TUBERCULOSTATIC AGENT;

ADVERSE OUTCOME; ALTERNATIVE MEDICINE; ARTICLE; CHINA; DRUG SAFETY; FALLOPIA MULTIFLORA; HUMAN; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TOXIC HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84879903935     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835f6889     Document Type: Article

References (27)

1. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf 2001; 24:483-490.
2. Grant LM, Rockey DC Drug-induced liver injury. Curr Opin Gastroenterol 2012; 28:198-202.
3. Holt M, Ju C. Drug-induced liver injury. Handb Exp Pharmacol 2010; 196: 3-27.
4. Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk ofliverdamage? World JGastroenterol 2010; 16:5651-5661.
5. Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007; 27: 465-474.
6. Zhang L, Yang X, Guo P, Tong Y. Retrospective study on Xiaohe tablet-related liver damage and discussion on risk control. Zhongguo Zhong Yao Za Zhi 2010; 35:2199-2203.
7. Xue M, Jiang ZZ, Wu T, Li J, Zhang L, Zhao Y, et al. Anti-inflammatory effects and hepatotoxicity of Tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats. Phytomedicine 2012; 19:998-1006.
8. Laird AR, Ramchandani N, de Goma EM, Avula B, Khan IA, Gesundheit N. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. J Clin Gastroenterol 2008; 42:861-862.
9. Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011; 13:289-301.
10. Li XH, Wu MX, Ye HZ, Chen WL, Lin JM, Zheng LP, et al. Experimental study on the suppression of sodium nitroprussiate-induced chondrocyte apoptosis by Tougu Xiaotong Capsule (3f*l?£?-containing serum. Chin J Integr Med 2011; 17:436-443.
11. Lucena MI, Kaplowitz N, Hallal H, Castiella A, García-Bengoechea M, Otazua P, et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011; 55:820-827.
12. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007; 370:2030-2043.
13. World Health Organization. Global tuberculosis report 2012. Report no. WHO/HTM/TB/2012.6. Available at: http://www.who.int/tb/publications/global- report/en/. [Accessed 2 November 2012].
14. Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet 2007; 369:691-696.
15. Ministry of Health of the People's Republic of China. Report on nationwide random survey for the epidemiology of tuberculosis in 2000. Beijing: Ministry of Health of the People's Republic of China 2002.
16. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
17. Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 2002; 40:353-358.
18. Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135:1924-1 934.
19. Wai CT. Presentation of drug-induced liver injury in Singapore. Singapore Med J 2006; 47:116-120.
20. Hu YY, Huang F. Chinese herb and drug-induced liver injury. Zhonghua Gan Zang Bing Za Zhi 2012; 20:173-175.
21. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence ofdrug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36:451-455.
22. Björnsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther 2010; 32:3-13.
23. Currie J, Lin W, Zhang W. Patient knowledge and antibiotic abuse: evidence from an audit study in China. J Health Econ 2011; 30:933-949.
24. Yang YH, Fu SG, Peng H, Shen AD, Yue SJ, Go YF, et al. Abuse of antibiotics in China and its potential interference in determining the etiology of pediatric bacterial diseases. Pediatr Infect Dis J 1993; 12:986-988.
25. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129:512-521.
26. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 2007; 6:673-684.
27. Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 2005; 42:481-489.